| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 45 |
| 1 | VIRAL LOAD INCREASED | 45 |
| 2 | DRUG INEFFECTIVE | 44 |
| 3 | RASH | 43 |
| 4 | HOSPITALISATION | 36 |
| 5 | FATIGUE | 30 |
| 6 | OFF LABEL USE | 30 |
| 7 | DIARRHOEA | 28 |
| 8 | NAUSEA | 26 |
| 9 | DEATH | 25 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | SOMATIC PAIN | 1 | 0.2000 |
| 1 | BLOOD HIV RNA | 4 | 0.0769 |
| 2 | CONGENITAL HIV INFECTION | 2 | 0.0513 |
| 3 | ANAL CANCER RECURRENT | 1 | 0.0476 |
| 4 | VULVAL CANCER STAGE 0 | 1 | 0.0179 |
| 5 | PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT | 11 | 0.0126 |
| 6 | T-LYMPHOCYTE COUNT DECREASED | 8 | 0.0117 |
| 7 | VIRAL LOAD INCREASED | 45 | 0.0116 |
| 8 | GENOTYPE DRUG RESISTANCE TEST POSITIVE | 11 | 0.0107 |
| 9 | MIDDLE CEREBRAL ARTERY STROKE | 1 | 0.0088 |